Fundraising Fox

LogicBio

Cambridge, US · Founded 2014 · Delaware corporation · 4 known investors

LogicBio is a biotechnology company focused on research and development of treatments for rare diseases, investigating new targets, modalities, and technologies for patients and their families worldwide.

BiotechHealthtech

Founders & leadership

LogicBio was founded in 2014 by Leszek Lisowski, Mark A. Kay, and Adi Barzel.

LL
Leszek LisowskiCo-founder
MA
Mark A. KayCo-founder
AB
Adi BarzelCo-founder

Board

EC
Erez ChimovitsBoard director

Investors · 4

Andera PartnersParis
Pontifax Venture CapitalHerzeliya · $6.3M – $128M
Arix BiosciencereportedLondon
OrbiMedreportedNew York · $1M – $75M

Reported raises · per SEC filings

Form D private placements

$33.2M disclosed across 2 rounds · 2016–2017

▶$29.2MraisedJul 2017 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • MARC RUBENSTEINExecutive Officer
  • TOMER KARIVDirector
  • MARK A. KAYDirector
  • LEON CHENDirector
  • EREZ CHIMOVITSDirector
  • SOFIA IOANNIDOUDirector
  • DANIEL O'CONNELLDirector
  • FREDERIC CHEREAUExecutive Officer, Director
Offering amount
$44.9M
Amount sold
$29.2M
First sale
Jun 2017
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4MraisedJan 2016 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Leszek LisowskiExecutive Officer, Director
  • Erez ChimovitsDirector
  • Mark A. KayDirector
  • Adi BarzelExecutive Officer, Director
Offering amount
$5.4M
Amount sold
$4M
Minimum investment
$1
First sale
Jan 2016
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

LogicBio Therapeutics (OTCMKTS:LOGC) Hits New 52-Week High – Should You Buy? - Markets Dailythemarketsdaily.com · Aug 2026LogicBio raises $70m in Nasdaq IPO - Globesen.globes.co.il · Oct 2018Gene Therapy Developer LogicBio Raises $70 Million in IPO - Global Genesglobalgenes.org · Oct 2018LogicBio Therapeutics Raises $45M in Series B Funding - FinSMEsfinsmes.com · Jun 2017Arix Bioscience Leads $45 Million Series B Financing Round Into LogicBio - BioSpacebiospace.com · Jun 2017OrbiMed-backed startup gets $4M for hemophilia gene therapymedcitynews.com · Jan 2016

Frequently asked questions

What does LogicBio do?
LogicBio is a biotechnology company focused on research and development of treatments for rare diseases, investigating new targets, modalities, and technologies for patients and their families worldwide.
Who founded LogicBio?
LogicBio was founded by Leszek Lisowski, Mark A. Kay, Adi Barzel in 2014.
Who are LogicBio's investors?
LogicBio's investors include Andera Partners, Pontifax Venture Capital, Arix Bioscience, OrbiMed.
How much funding has LogicBio raised?
LogicBio has disclosed $33.2M raised across 2 rounds.
Where is LogicBio headquartered?
LogicBio is headquartered in Cambridge, US.